These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9498729)

  • 1. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1997 Mar; 130(2):159-65. PubMed ID: 9106914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.
    King GR; Xiong Z; Douglass S; Ellinwood EH
    Eur J Pharmacol; 2000 Apr; 394(1):97-101. PubMed ID: 10771040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration.
    Davidson C; Lee TH; Xiong Z; Ellinwood EH
    Neuropsychopharmacology; 2002 Oct; 27(4):542-53. PubMed ID: 12377391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration.
    King GR; Xiong Z; Ellinwood EH
    Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal.
    King GR; Joyner C; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Dec; 49(4):883-9. PubMed ID: 7886102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal.
    King GR; Joyner C; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):451-7. PubMed ID: 8208762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ondansetron administration on opioid withdrawal syndrome observed in rats.
    Pinelli A; Trivulzio S; Tomasoni L
    Eur J Pharmacol; 1997 Dec; 340(2-3):111-9. PubMed ID: 9537805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine.
    King GR; Pinto G; Konen J; Castro G; Tran S; Hilburn C
    Eur J Pharmacol; 2002 Aug; 449(3):253-9. PubMed ID: 12167467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist.
    Roychoudhury M; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):677-83. PubMed ID: 9121224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats.
    Szumlinski KK; Frys KA; Kalivas PW
    Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization.
    Davidson C; Lazarus C; Xiong X; Lee TH; Ellinwood EH
    Eur J Pharmacol; 2002 Oct; 453(2-3):255-63. PubMed ID: 12398913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine.
    Matell MS; King GR
    Psychopharmacology (Berl); 1997 Apr; 130(3):242-8. PubMed ID: 9151358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron.
    Suzuki T; Ise Y; Mori T; Misawa M
    Life Sci; 1997; 61(16):PL249-54. PubMed ID: 9353175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent and continuous cocaine administration: residual behavioral states during withdrawal.
    King GR; Joyner C; Lee T; Kuhn C; Ellinwood EH
    Pharmacol Biochem Behav; 1992 Sep; 43(1):243-8. PubMed ID: 1409810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity.
    Zhang X; Mi J; Wetsel WC; Davidson C; Xiong X; Chen Q; Ellinwood EH; Lee TH
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1144-50. PubMed ID: 16414349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion.
    King GR; Joyner C; Lee TH; Ellinwood EH
    Pharmacol Biochem Behav; 1993 Feb; 44(2):253-62. PubMed ID: 8446658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal from continuous or intermittent cocaine: behavioral responsivity to 5-HT1 receptor agonists.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1993 Jul; 45(3):577-87. PubMed ID: 8332619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice.
    Umathe SN; Bhutada PS; Raut VS; Jain NS; Mundhada YR
    Behav Pharmacol; 2009 Feb; 20(1):78-83. PubMed ID: 19106764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.